RU94028273A - Фармацевтические композиции, обладающие хорошей растворимостью, способ ее сохранения и улучшения - Google Patents

Фармацевтические композиции, обладающие хорошей растворимостью, способ ее сохранения и улучшения

Info

Publication number
RU94028273A
RU94028273A RU94028273/14A RU94028273A RU94028273A RU 94028273 A RU94028273 A RU 94028273A RU 94028273/14 A RU94028273/14 A RU 94028273/14A RU 94028273 A RU94028273 A RU 94028273A RU 94028273 A RU94028273 A RU 94028273A
Authority
RU
Russia
Prior art keywords
agents
optionally
film
ifetroban
good solubility
Prior art date
Application number
RU94028273/14A
Other languages
English (en)
Russian (ru)
Inventor
Никфар Фаранак
Ir]
Т.М.Сераджуддин Абу
Л.Ежевски Роберт
Us]
Б.Джайн Немичанд
Original Assignee
Бристоль-Майерз Сквибб Компани (US)
Бристоль-Майерз Сквибб Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бристоль-Майерз Сквибб Компани (US), Бристоль-Майерз Сквибб Компани filed Critical Бристоль-Майерз Сквибб Компани (US)
Publication of RU94028273A publication Critical patent/RU94028273A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU94028273/14A 1993-08-02 1994-08-01 Фармацевтические композиции, обладающие хорошей растворимостью, способ ее сохранения и улучшения RU94028273A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10080293A 1993-08-02 1993-08-02
US100802 1993-08-02

Publications (1)

Publication Number Publication Date
RU94028273A true RU94028273A (ru) 1996-11-10

Family

ID=22281616

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94028273/14A RU94028273A (ru) 1993-08-02 1994-08-01 Фармацевтические композиции, обладающие хорошей растворимостью, способ ее сохранения и улучшения

Country Status (15)

Country Link
EP (1) EP0638310A1 (enExample)
JP (1) JPH07145052A (enExample)
KR (1) KR950005309A (enExample)
CN (1) CN1118254A (enExample)
AU (1) AU6878294A (enExample)
CA (1) CA2129099A1 (enExample)
CZ (1) CZ181094A3 (enExample)
FI (1) FI943569A7 (enExample)
HU (1) HUT70951A (enExample)
IL (1) IL110376A (enExample)
NO (1) NO942854L (enExample)
NZ (1) NZ264129A (enExample)
PL (1) PL304508A1 (enExample)
RU (1) RU94028273A (enExample)
ZA (1) ZA945672B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0839526A3 (en) * 1996-10-31 1999-01-07 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation with fast buccal disintegration or dissolution
CN1195500C (zh) 1998-05-18 2005-04-06 武田药品工业株式会社 可口腔崩解的片剂
CA2581111A1 (en) 1998-07-28 2000-02-10 Takeda Pharmaceutical Company Limited Rapidly disintegrable solid preparation
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
JP4698000B2 (ja) * 2000-06-27 2011-06-08 旭化成ケミカルズ株式会社 水易溶性薬物含有錠剤
WO2002072069A1 (en) * 2001-03-12 2002-09-19 Novo Nordisk A/S Novel tablets and capsules and a process for its preparation
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
DE10341414A1 (de) * 2003-09-05 2005-03-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Oral zu applizierende Darreichungsform für schwerlösliche saure und amphotere Wirkstoffe
CN100438914C (zh) * 2003-10-15 2008-12-03 富士化学工业株式会社 用于口腔内快速崩解的片剂的组合物
JP3841804B2 (ja) 2003-10-15 2006-11-08 富士化学工業株式会社 口腔内速崩壊性錠剤用の組成物
US8349361B2 (en) 2003-10-15 2013-01-08 Fuji Chemical Industry Co., Ltd. Composition for rapid disintegrating tablet in oral cavity
EA015304B1 (ru) 2006-08-03 2011-06-30 Нитек Фарма Аг Лечение ревматоидного заболевания глюкокортикоидами с отсроченным высвобождением
MY149356A (en) 2007-03-29 2013-08-30 Daiichi Sankyo Co Ltd Pharmaceutical composition
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
GB201400034D0 (en) * 2014-01-02 2014-02-19 Astrazeneca Ab Pharmaceutical Compositions comprising AZD9291
EP3804717A1 (en) 2014-05-16 2021-04-14 Cumberland Pharmaceuticals, Inc. Compositions and methods of treating systemic sclerosis or pulmonary arterial hypertension
US12161632B2 (en) 2014-05-16 2024-12-10 Cumberland Pharmaceuticals Inc. Compositions and methods of treating cardiac fibrosis with ifetroban
MX2017017155A (es) 2015-06-30 2018-08-09 Cumberland Pharmaceuticals Inc Antagonistas del receptor de tromboxano en erea/asma.
US12427121B2 (en) 2016-05-05 2025-09-30 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
US12433850B2 (en) 2016-05-05 2025-10-07 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine and prodrug compositions
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
CN109310646A (zh) 2016-05-05 2019-02-05 阿奎斯蒂弗医疗股份有限公司 增强递送的肾上腺素组合物
EP3454850B1 (en) 2016-05-11 2023-06-21 Cumberland Pharmaceuticals Inc. Compositions and methods of treating muscular dystrophy with thromboxane-a2 receptor antagonists
US12465564B2 (en) 2021-10-25 2025-11-11 Aquestive Therapeutics, Inc. Oral and nasal compositions and methods of treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100889A (en) * 1989-04-03 1992-03-31 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
DD299186A5 (de) * 1990-10-01 1992-04-02 E.R. Squibb U. Sons,Inc.,Us Phenylen-7-oxabicycloheptyl-substituierte heterocycloamid-prostaglandinanaloga

Also Published As

Publication number Publication date
CN1118254A (zh) 1996-03-13
EP0638310A1 (en) 1995-02-15
CZ181094A3 (en) 1995-02-15
AU6878294A (en) 1995-02-09
CA2129099A1 (en) 1995-02-03
NO942854L (no) 1995-02-03
FI943569L (fi) 1995-02-03
IL110376A0 (en) 1994-10-21
FI943569A7 (fi) 1995-02-03
FI943569A0 (fi) 1994-07-29
KR950005309A (ko) 1995-03-20
HU9402254D0 (en) 1994-09-28
IL110376A (en) 1998-08-16
NO942854D0 (enExample) 1994-08-01
NZ264129A (en) 1996-05-28
PL304508A1 (en) 1995-02-06
JPH07145052A (ja) 1995-06-06
ZA945672B (en) 1995-03-06
HUT70951A (en) 1995-11-28

Similar Documents

Publication Publication Date Title
RU94028273A (ru) Фармацевтические композиции, обладающие хорошей растворимостью, способ ее сохранения и улучшения
US6423351B2 (en) Inhibiting oxidative degradation of pharmaceutical formulations
EP1310245B1 (en) Clopidogrel bisulfate tablet formulation
US6106862A (en) Once daily analgesic tablet
CA2340052A1 (en) Pharmaceutical compositions containing lipase inhibitors and chitosan
CA2452738A1 (en) Gastric retention controlled drug delivery system
CA2164776A1 (en) Pharmaceutical, orally applicable composition
US6509037B2 (en) Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof
CO4700474A1 (es) Formulacion oral de 2-metil-tieno-benzodiacepina
CA2214100A1 (en) Sustained release formulation containing three different types of polymers
BR0311261A (pt) Composição lìquida aquosa branqueadora dos dentes, e, método para branquear os dentes
RU95101048A (ru) Производные пролинамида, фармкомпозиция на их основе
CA2470601A1 (en) Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
CA2316485A1 (en) Sustained-release pharmaceutical composition
CZ2001792A3 (cs) Farmaceutická kompozice obsahující entakapon a nitakapon a zesíťovaný derivát celulózy
RU96116411A (ru) Быстро распадающаяся готовая препаративная форма трамадола или соли трамадола
HUP9900154A2 (hu) Trovafloxacin-mezilát tabletta
SE0102843D0 (sv) Stabilized oral pharmaceutical composition containing lodide and lodate and method
CA2338794A1 (en) New oral formulation for 5-ht4 agonists or antagonists
IT8423263A1 (it) Formulazioni farmaceutiche acquose di piroxicam monoidrato
CA2161533A1 (en) Indole Derivatives
CA2119346A1 (en) Solid pharmaceutical dosage form and a method for reducing abrasion
HUP9900856A2 (hu) Lúgosító káliumsót magában foglaló szabályozott hatóanyag-leadású készítmények
KR890001535A (ko) 요독증의 치료에 유용한 약학 조성물
JP2002316928A (ja) コーティング錠及びコーティング錠のはがれを防止する方法